Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ETR/FIE stock hub

ETR/FIE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/FIEis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.5B
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/FIE
In the news

Latest news · ETR/FIE

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.7
P25 12.3P50 15.7P75 20.2
Trailing P/E17.3
P25 16.4P50 20.9P75 30.4
ROE21.5
P25 -6.7P50 8.5P75 17.2
ROIC14.2
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/FIE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
204
Groups with data
10
Currency
EUR
Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Germany
Country code
DE
Employees
18,928
Employees Change
-5,435%
Employees Change Percent
-22.31
Enterprise value
EUR 4.2B
Exchange
Deutsche Börse Xetra
Financial currency
EUR
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
DE0005772206
Last refreshed
2026-05-10
Market cap
EUR 3.5B
Price
EUR 42.2
Price currency
EUR
Rev Per Employee
131,572.51x
Sector
Healthcare
Sic
3851
Symbol
etr/FIE
Website
https://www.fielmann-group.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
5.78%
EV Earnings
20.56x
EV/EBIT
12.68x
EV/EBITDA
7.5x
EV/Sales
1.72x
Forward P/E
15.69x
P/B ratio
3.55x
P/E ratio
17.32x
P/S ratio
1.45x
PE Ratio10 Y
31.63x
PE Ratio3 Y
25.76x
PE Ratio5 Y
27.86x
PEG ratio
0.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
13.59%
EBITDA Margin
17.87%
Gross margin
80.11%
Gross Profit
EUR 2B
Gross Profit Growth
4.53%
Gross Profit Growth Q
2.16%
Gross Profit Growth3 Y
11.1%
Gross Profit Growth5 Y
10.56%
Net Income
EUR 204.9M
Net Income Growth
23.78%
Net Income Growth Q
2.12%
Net Income Growth Quarters
5%
Net Income Growth Years
3%
Net Income Growth3 Y
23.3%
Net Income Growth5 Y
9.24%
Pretax Margin
12%
Profit Margin
8.39%
Profit Per Employee
EUR 11,033
Profitable Years
24
Roa5y
7.15
ROE
21.5
Roe5y
16.69
ROIC
14.17
Roic5y
11.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr10y
-1.91%
Cagr15y
3.63%
Cagr1y
-20.3%
Cagr20y
6.91%
Cagr3y
-1.97%
Cagr5y
-5.93%
Div CAGR10
-2.21%
Div CAGR3
23.13%
Div CAGR5
3.13%
EPS Growth
23.4
EPS Growth Q
1.54
EPS Growth Quarters
5
EPS Growth Years
3
EPS Growth3 Y
23.14
EPS Growth5 Y
9.01
Revenue Growth
4.26x
Revenue Growth Q
1.34x
Revenue Growth Quarters
20x
Revenue Growth Years
5x
Revenue Growth3 Y
10.27x
Revenue Growth5 Y
10.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
EUR 226.9M
Debt
EUR 879.8M
Debt EBITDA
EUR 1.57
Debt Equity
EUR 0.88
Equity
EUR 998.2M
Interest Coverage
7.45
Net Cash
EUR -653M
Net Cash By Market Cap
EUR -18.43
Net Debt EBITDA
EUR 1.5
Net Debt Equity
EUR 0.65
Tangible Book Value
EUR 305.3M
Tangible Book Value Per Share
EUR 3.64
WACC
6.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-0.31%
Dividend Growth
21.74%
Dividend Growth Years
2%
Dividend per share
EUR 1.4
Dividend Years
6
Dividend Yield
3.32%
Ex Div Date
2026-07-10
Last Dividend
EUR 1.4
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-17.51%
1Y total return
-20.29%
200-day SMA
46.94
3Y total return
-5.8%
50-day SMA
44.06
50-day SMA vs 200-day SMA
50under200
5Y total return
-26.33%
All Time High
77.7
All Time High Change
-45.69%
All Time High Date
2017-10-26
All Time Low
2.13
All Time Low Change
1,882.15%
All Time Low Date
1998-01-30
ATR
1.19
Beta
0.61
Beta1y
0.87
Beta2y
0.9
Ch YTD
-3.1
High
42.8
High52
58.8
High52 Date
2025-07-11
High52ch
-28.23%
Low
42
Low52
39.85
Low52 Date
2026-01-21
Low52ch
5.9%
Ma50ch
-4.22%
Price vs 200-day SMA
-10.11%
RSI
40.31
RSI Monthly
44.29
RSI Weekly
42.85
Sharpe ratio
-1.05x
Sortino ratio
-1.25
Total Return
3%
Tr YTD
-3.1
Tr15y
70.69%
Tr1m
-2.43%
Tr1w
-0.35%
Tr3m
0.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 332M
Operating Income Growth
20.25
Operating Income Growth Q
2.86
Operating Income Growth3 Y
23.64
Operating Income Growth5 Y
13.73
Operating margin
13.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
22,735,113%
Shares Insiders
17.91%
Shares Institutions
8.44%
Shares Out
83,958,471
Shares Qo Q
1%
Shares Yo Y
0.31%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Average Volume
63,300.1x
Bv Per Share
11.69
Ch10y
-34.24
Ch15y
16.66
Ch1m
-2.43
Ch1w
-0.35
Ch1y
-21.85
Ch20y
122.7
Ch3m
0.24
Ch3y
-11.08
Ch5y
-34.27
Ch6m
-4.85
Change
-1.4%
Change From Open
0.24
Close
42.8
Days Gap
-1.64
Depreciation Amortization
104,774,250
Dollar Volume
2,418,861.8
Earnings Date
2026-04-30
EBIT
EUR 332M
EBITDA
EUR 436.7M
EPS
EUR 2.44
F Score
2
Fiscal Year End
December
Founded
1,972
Graham Number
25.55015
Graham Upside
-39.45
Income Tax
EUR 86.6M
Is Primary Listing
1
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Last Split Date
2014-08-22
Last Split Type
Forward
Lynch Fair Value
EUR 22.54
Lynch Upside
-46.58
Ma150
44.42
Ma150ch
-4.99%
Ma20
44.69
Ma20ch
-5.57%
Next Earnings Date
2026-08-27
Open
42.1
Payment Date
2026-07-14
Position In Range
25
Price Date
2026-05-08
Price EBITDA
EUR 8.11
Ptbv Ratio
11.6
Relative Volume
0.91x
Revenue
2,443,433,000x
Tax By Revenue
3.54x
Tax Rate
29.54%
Tr20y
280.54%
Tr6m
-4.85%
Volume
57,319
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

ETR/FIE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.3%
$1.40 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+3.1%
2 consecutive years of growth
Total shareholder yield
+3.0%
Next ex-dividend date: 2026-07-10
Performance

ETR/FIE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-20.3%
S&P 500 1Y: n/a
3Y total return
-5.8%
S&P 500 3Y: n/a
5Y total return
-26.3%
S&P 500 5Y: n/a
10Y total return
-17.5%
S&P 500 10Y: n/a
Ownership

Who owns ETR/FIE?

Insider, institutional, and short-interest positioning.

Institutional ownership
+8.4%
Share of float held by funds and institutions
Insider ownership
+17.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.3%
Negative means the company is buying back shares.
Technical

ETR/FIE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
40.3
Neutral momentum band
Price vs 200-day MA
-10.1%
50/200-day relationship not available
Beta (5Y)
0.61
Less volatile than the market
Sharpe ratio
-1.05
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/FIE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/FIE stock rating?

etr/FIE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/FIE analysis?

The full report lives at /stocks/etr/FIE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/FIE?

The latest report frames etr/FIE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/FIE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.